Fecal microbiota transplantation may transmit COVID-19, FDA warns

The FDA warned clinicians the SARS-CoV-2 virus, which causes COVID-19, may be transmitted in fecal samples during fecal microbiota transplants.

Advertisement

What you should know:

1. Although transmission risk during FMT remains unknown, because of the possibility, the FDA has recommended additional safety precautions.

2. The FDA recommends clinicians or researchers use stool donated before Dec. 1, 2019, whenever possible.

3. If stool from before Dec. 1 is not available, clinicians or researchers should screen donors for COVID-19, test donors or the stool for COVID-19, and develop informed consent forms that warn of potential transmission.

Read the entire briefing here.

More articles on ASC news:
Regent Surgical Health responds to COVID-19: 3 things to know
When will the coronavirus peak? It’s complicated
Hospitals looking into using ASCs for COVID-19 patients: 4 things to know

Advertisement

Next Up in GI & Endoscopy

  • General gastroenterologists earn an average base salary of $526,273 — more than $218,000 higher than their pediatric counterparts, who report…

  • The MUSC Shawn Jenkins Children’s Hospital in Charleston, S.C., has launched the MUSC Advanced Pediatric Endoscopy Program and Pancreas Center. …

Advertisement

Comments are closed.